Cited by 67Retinal Diseases and TreatmentsMicroRNA in disease regulationRetinal Development and Disorders

miRNAs as potential therapeutic targets for age-related macular degeneration

Open access
Wang, Shusheng, Koster, Kyle M, He, Yuguang, Zhou, Qinbo·2012·Future Medicinal Chemistry

Abstract

Since their recent discovery, miRNAs have been shown to play critical roles in a variety of pathophysiological processes. Such processes include pathological angiogenesis, the oxidative stress response, immune response and inflammation, all of which have been shown to have important and interdependent roles in the pathogenesis and progression of age-related macular degeneration (AMD). Here we present a brief review of the pathological processes involved in AMD and review miRNAs and other noncoding RNAs involved in regulating these processes. Specifically, we discuss several candidate miRNAs that show promise as AMD therapeutic targets due to their direct involvement in choroidal neovascularization or retinal pigment epithelium atrophy. We discuss potential miRNA-based therapeutics and delivery methods for AMD and provide future directions for the field of miRNA research with respect to AMD. We believe the future of miRNAs in AMD therapy is promising.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4155/fmc.11.176

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wang, S., Koster, K. M., He, Y., & Zhou, Q.
Affiliations
  • The University of Texas Southwestern Medical Center (US)
  • Department of Ophthalmology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX75390, USA
Corresponding author
Wang, Shusheng
Venue
Future Medicinal Chemistry
Published
2012-03
Volume
4
Issue
3
Pages
277-287
ISSN
  • 1756-8919 (ISSN-L)
  • 1756-8927
OpenAlex
W2151225614
Cited by
67
References
110
Citations by year
2026: 3 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 5 · 2018: 7 · 2017: 7 · 2016: 7 · 2015: 6 · 2014: 6 · 2013: 2 · 2012: 1
FWCI
0.74
Type
journal article
Language
en
Open access
Locations
  • Future Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
UT Southwestern Medical Center (EY021862 and EY020799)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
Keywords
microRNA, age-related macular degeneration, therapeutic target, choroidal neovascularization, retinal pigment epithelium atrophy, pathological angiogenesis, oxidative stress, inflammation, non-coding RNA, miRNA-based therapy, microRNA delivery
MeSH terms
Animals, Humans, Inflammation, Macula Lutea, Macular Degeneration, Oxidative Stress, Choroidal Neovascularization, MicroRNAs, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review